Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KUS-121 by Kyoto Drug Discovery & Development for Retinal Artery Occlusion: Likelihood of Approval
KUS-121 is under clinical development by Kyoto Drug Discovery & Development and currently in Phase II for Retinal Artery Occlusion....